- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (718)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (626)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (64)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (896)
- Research (390)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (604)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (322)
- Symptoms (184)
- Treatment (1774)
Andrew Sabin Family Fellows awarded $100,000 in research funding
BY Sarah Watson
2 minute read | Published May 10, 2017
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on May 10, 2017
Eight MD Anderson researchers have been named 2017 Andrew Sabin Family Fellows. The Andrew Sabin Family Fellowship Program provides $100,000 in funding per fellow over two years through a $30 million endowed gift to encourage research creativity, independent thinking and high-impact cancer research.
“It’s been exciting to observe last year’s inaugural eight fellows as their research has progressed during the first year of the program, and we’re equally impressed with the 2017 class,” said Sabin, who has served on the MD Anderson Cancer Center Board of Visitors since 2005. “The program now nurtures 16 brilliant minds focused on finding an end to this terrible disease. My family looks forward to seeing their impact grow exponentially over the coming year. We’re proud to know our gift already is making a difference for people suffering from cancer.”
The awardees and their areas of focus are:
- Margarida Albuquerque Almeida Santos, Ph.D., assistant professor, Epigenetics and Molecular Carcinogenesis: the role of DNA repair factors, or genome guardians, in promoting tumors
- Swathi Arur, Ph.D., associate professor, Genetics: interplay of RAS signaling and small RNA biogenesis enzymes in promoting tumor progression and metastasis
- Boyi Gan, Ph.D., assistant professor, Experimental Radiation Oncology: the role of energy sensing and metabolism in cancer
- Clifton Fuller, M.D., Ph.D., assistant professor, Radiation Oncology: developing and implementing “Big Data” approaches to imaging methodologies to treat head and neck cancers more effectively
- Chad Huff, Ph.D., assistant professor, Epidemiology: understanding human evolution and the genetic basis of disease through statistical, computational and population genomics
- Eugene Koay, M.D., Ph.D., assistant professor, Radiation Oncology: developing and validating a method using CT scans to measure response in pancreatic cancer patients
- Andrew Rhim, M.D., assistant professor, Gastroenterology, Hepatology and Nutrition: how precancerous pancreatic lesions transform into cancer and how tumors become resistant to therapy through mutations
- Jennifer Wargo, M.D., MMSc, associate professor, Surgical Oncology and Genomic Medicine: delineating the role of the gut microbiome in modulating responses to cancer immunotherapy
The Andrew Sabin Family Fellowship program awards up to eight cancer research fellowships annually to support research that pushes the envelope in four categories: basic science, clinical, physician-scientist and population and quantitative science. The funding over two years frees young researchers to pursue potentially practice-changing science rather than spend the bulk of their time writing grants.
Sabin is president of Sabin Metal Corporation, the largest privately owned precious metals refiner and recycler in the country. An avid environmentalist, conservationist and wildlife enthusiast, he devotes much of his time and energy to advocating on a national level for increased cancer research funding.
It’s been exciting to observe last year’s inaugural eight fellows as their research has progressed during the first year of the program, and we’re equally impressed with the 2017 class.
Andrew Sabin